Nanologica: Strong outlook for 2024 - Redeye

Redeye updates its view and outlook on Nanologica following the company’s year-end report and announcement of a fully guaranteed rights issue. We make minor revisions to our estimates and adjust our valuation for the dilution, leading to a new fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/974836/nanologica-q4-2023-strong-outlook-for-2024?utm_source=finwire&utm_medium=RSS